Non-immunoglobulin scaffold proteins: Precision tools for studying protein-protein interactions in cancer

New Biotechnology
Heather L MartinDarren C Tomlinson

Abstract

Cancer is frequently characterised by dysregulation of the cellular signalling processes that govern proliferation, survival and attachment. Understanding such dysregulation continues to present a challenge given the importance of protein-protein interactions in intracellular processes. Exploring this protein-protein interactome requires novel tools capable of discriminating between highly homologous proteins, individual domains and post-translational modifications. This review examines the potential of scaffold-based binding proteins to fulfil these requirements. It also explores protein-protein interactions in the context of intracellular signalling pathways and cancer, and demonstrates the uses of scaffold proteins as functional moderators, biosensors and imaging reagents. This review also highlights the timeliness and potential to develop international consortia to develop and validate highly specific "proteome" scaffold-based binding protein reagents with the ultimate aim of developing screening tools for studying the interactome.

References

Oct 30, 1998·Cellular Signalling·R J Daly
Dec 1, 1999·Cell Death and Differentiation·P G EkertD L Vaux
Nov 1, 2000·Cell·J Schlessinger
Dec 15, 2000·Oncogene·R B Irby, T J Yeatman
Jul 30, 2003·Cancer Metastasis Reviews·Justin M Summy, Gary E Gallick
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
Jun 26, 2004·Chemistry & Biology·Ece KaratanBrian K Kay
Oct 19, 2004·Oncogene·Sarah J Parsons, J Thomas Parsons
Jan 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Helen S Bell, Kevin M Ryan
Aug 30, 2005·Molecular & Cellular Proteomics : MCP·Mathias UhlénFredrik Pontén
Mar 23, 2006·Protein Engineering, Design & Selection : PEDS·Patrick AmstutzAndreas Plückthun
May 15, 2007·Oncogene·A S DhillonW Kolch
Feb 13, 2008·Biochimica Et Biophysica Acta·Young-Mi Go, Dean P Jones
Aug 1, 2009·Nature Reviews. Drug Discovery·Pixu LiuJean J Zhao
Feb 12, 2010·Nature Reviews. Cancer·Maria Kavallaris
Apr 2, 2010·Nature Structural & Molecular Biology·John WojcikShohei Koide
Apr 10, 2010·Clinical Colorectal Cancer·Christopher Lieu, Scott Kopetz
Jun 15, 2010·FEBS Letters·Luke W ThomasSteven W Edwards
Jul 1, 2010·PLoS Computational Biology·Javier De Las Rivas, Celia Fontanillo
Feb 5, 2011·Current Opinion in Structural Biology·Lei XiePhilip E Bourne
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ryan N GilbrethShohei Koide
May 28, 2011·Protein Engineering, Design & Selection : PEDS·Lukas Kurt Josef StadlerPaul Ko Ferrigno
Jun 15, 2011·Nature Chemical Biology·Akash GulyaniKlaus M Hahn
Oct 18, 2011·Cell·Florian GrebienGiulio Superti-Furga
Dec 14, 2011·Trends in Pharmacological Sciences·Siyuan Zhang, Dihua Yu
Jan 31, 2012·Chemistry & Biology·Tinghu ZhangNathanael S Gray
Feb 14, 2012·Structure·Vidhyashankar RamamurthySteven Sheriff
Mar 23, 2012·Cold Spring Harbor Perspectives in Biology·Paul Polakis
Jun 12, 2012·Aging·Bartolo FavaloroVincenzo De Laurenzi
Jul 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ludovic PecqueurMarcel Knossow
Jul 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lutz KummerAndreas Plückthun
Dec 12, 2012·ACS Chemical Biology·Jasdeep K MannSheldon Park
Apr 3, 2013·Biochimica Et Biophysica Acta·Martin Scheffner, Sharad Kumar
Jun 26, 2013·Chemistry & Biology·Lutz KummerAndreas Plückthun
Jul 12, 2013·Nature Reviews. Cancer·Emileigh K GreuberAnn Marie Pendergast
Sep 18, 2013·The Biochemical Journal·Anja BerndtJeremy M Henley
Dec 21, 2013·Current Opinion in Chemical Engineering·Lawrence A SternBenjamin J Hackel
Mar 29, 2014·Protein Engineering, Design & Selection : PEDS·Christian TiedeMichael J McPherson

❮ Previous
Next ❯

Citations

Sep 12, 2018·Endocrinology·Yves Mugabo, Gareth E Lim
Jun 23, 2019·Scientific Reports·Matja ZalarAlexander P Golovanov
Mar 27, 2019·Current Opinion in Chemical Biology·Mengqi ZhongMichelle R Arkin
Jun 23, 2021·Nature Communications·Georgios N HatzopoulosPierre Gönczy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Related Papers

Biochemical Society Transactions
Viduth K Chaugule, Helen Walden
Advances in Experimental Medicine and Biology
Ezra BlumenthalStephen D Nimer
The International Journal of Biochemistry & Cell Biology
Daniel HorbeltPetra Knaus
Mechanisms of Ageing and Development
Andrea Princz, Nektarios Tavernarakis
© 2022 Meta ULC. All rights reserved